• Home
  • About Us
    • Our Company
    • Our Vision
    • Our Board of Directors
    • Our Management Team
    • Scientific Advisory Board
  • Products
    • Telitacicept
    • Disitamab Vedotin
    • Product Pipeline
    • Production and Manufacturing
    • Quality Assurance
  • R & D
    • Renovation Capabilities
    • Technology Platform
    • Talent Team
  • Investors
    • Information Disclosure
    • Corporate Governance
    • IR Contacts
  • News
    • Company News
    • Press Release
  • Join Us
    • Recruitment
    • Working at RemeGen
  • Contact Us
    • Company Address
    • Clinical Trial
    • Products Consulting
    • Human Resource
    • Adverse drug reaction reports
  • Lang
    • 中文简体
    • 中文繁体

Media Resources

Media Resources

Information for Media Professionals

// Molecule
// Laboratory
// RemeGen Building
// logo

About Us

  • Our Company
  • Our Vision
  • Our Board of Directors
  • Our Management Team
  • Scientific Advisory Board

Products

  • Telitacicept
  • Disitamab Vedotin
  • Product Pipeline
  • Production and Manufacturing
  • Quality Assurance

R & D

  • Renovation Capabilities
  • Technology Platform
  • Talent Team

Investors

  • Information Disclosure
  • Corporate Governance
  • IR Contacts

News

  • Company News
  • Press Release

Join Us

  • Recruitment
  • Working at RemeGen

Contact Us

  • Company Address
  • Clinical Trial
  • Products Consulting
  • Human Resource
  • Adverse drug reaction reports

58 Beijing Middle Road, Yantai Shandong, China.

(+86)0535-3573511

Company Wechat
Company Wechat

鲁公网安备37069302889101工信部网站备案号:鲁ICP备11031710号-4